An anonymous $75 million gift to NYU Langone Health and its Laura and Isaac Perlmutter Cancer Center will establish a Center for Blood Cancers housing a new, world-class program for multiple myeloma care and research, along with other blood cancer programs. The new center will significantly expand Perlmutter Cancer Center’s capacity to study and treat blood cancers.
In addition, the new center will expand research capabilities focusing on clinical trial recruitment and efforts to identify markers for different cancer types to recognize blood cancers at their earliest stages.
“There is a pressing need for more research in the areas of early diagnosis and prevention of blood cancers,” says Benjamin G. Neel, MD, PhD, director of Perlmutter Cancer Center. “This gift will help us as attract new talent, leaders, and added expertise to further our mission to prevent and treat these deadly diseases.”
Learn more about the Center for Blood Cancers.